Showing results (431-440 of 444) with videos related to

Sort By:
Pageof 45
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 17, 2020
Olfactory and Gustatory Dysfunction as an Early Identifier of COVID-19 in Adults and Children: An International Multicenter StudyChenghao Qiu, Chong Cui, Charlotte Hautefort, et al.
Emerging Microbes & Infections|March 11, 2021
Pre-optimized phage therapy on secondary <i>Acinetobacter baumannii</i> infection in four critical COVID-19 patientsNannan Wu, Jia Dai, Mingquan Guo, et al.
Eclinicalmedicine|April 15, 2024
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, George Zhang, John Mao, et al.
Nature Microbiology|June 30, 2022
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, et al.
The European Respiratory Journal|March 19, 2026
Clinical practice guideline for long COVID prevention and treatmentBin Cao, Joan B Soriano, Quanyi Wang, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Eclinicalmedicine|January 8, 2024
Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialYangqing Zhan, Zhengshi Lin, Jingyi Liang, et al.
Bioscience Trends|October 29, 2025
Chinese expert consensus on the combined use of antiviral drugs for influenzaJing Yuan, Haimei Zhang, Rongrong Zou, et al.
Med (New York, N.Y.)|January 5, 2024
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M<sup>pro</sup> and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19Long Mao, Namir Shaabani, Xiaoying Zhang, et al.
The Science of the Total Environment|August 5, 2024
Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategyYinghui Li, Chen Du, Ziquan Lv, et al.
Pageof 45